Voter Guide / California Bills

AB 1460, explained

Prescription drug pricing.

Active In Committee Process · Author: Rogers

In plain English

This bill would stop drug manufacturers from punishing community clinics that participate in a federal discount program (called 340B) if those clinics use certain pharmacies to dispense drugs. It would make sure these clinics can still get the discounted prices the federal program promises, even when they use outside pharmacies to fill prescriptions.

If this passes

What would actually change, according to the bill's official digest. No predictions, no opinions.

Who's lobbying this bill

48 organizations reported lobbying activity mentioning this bill. California disclosures don't say which side an organization is on, only that they paid to influence it. Amounts shown are payments to lobbying firms where the filing discloses them.

California Life Sciences
paid to lobbying firms, quarters naming this bill · 3 filings
$180K
Pharmaceutical Research And Manufacturers Of America (Phrma)
paid to lobbying firms, quarters naming this bill · 4 filings
$168K
Sloat Higgins Jensen & Associates
paid to lobbying firms, quarters naming this bill · 6 filings
$168K
What you do with this is up to you. BallotBase doesn't rate, rank, or endorse candidates or measures. Every number on this page comes from official disclosure filings, cited below.
Sources

Explainer text is generated from the official source text above and reviewed for neutrality: it describes only what the text says, in conditional terms, with no evaluations or predictions. Spot an error? Tell us and we'll fix it.

← Back to all bills & measures · Voter Guide home